Aziz Khanifar, MD
Retina Specialist · Silver Spring, MDNPI 1053327445
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $61,048 of the $83,377 with a category attached, or 73.2%. 23 manufacturers reported payments, led by Genentech USA, Inc. at 49.9% of the total. Reporting peaked in 2023 at $27,561 and has fallen 64.1% since, to $9,894 in 2025. Among retina specialist clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $402.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$42K
- Regeneron Healthcare Solutions, Inc.$18K
- Astellas Pharma US Inc$10K
- Novartis$7K
- AbbVie$3K
- Apellis Pharmaceuticals, Inc.$1K
- plus $3K from 17 others
What the payments were for
- Consulting fees$9,52511%
- Speaking & faculty fees$61,04873%
- Travel & lodging$3,7364%
- Food & beverage$9,06711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 54 | $41,633 |
| Regeneron Healthcare Solutions, Inc. | 24 | $18,226 |
| Astellas Pharma US Inc | 22 | $10,199 |
| Novartis | 18 | $6,873 |
| AbbVie(2 entities) | 38 | $2,725 |
| Apellis Pharmaceuticals, Inc. | 17 | $1,107 |
| Alcon | 5 | $527 |
| Neurotech Pharmaceuticals, Inc. | 2 | $412 |
| Ocular Therapeutix, Inc. | 4 | $287 |
| Bausch & Lomb Americas Inc. | 2 | $240 |
| Alimera Sciences, Inc. | 7 | $166 |
| Genentech, Inc. | 1 | $150 |
| Carl Zeiss Meditec USA, Inc. | 1 | $128 |
| Dompe US, Inc. | 1 | $121 |
| Sun Pharmaceutical Industries Inc. | 1 | $116 |
| Sight Sciences, Inc. | 1 | $104 |
| Oyster Point Pharma, Inc. | 1 | $95 |
| Dutch Ophthalmic, USA | 1 | $88 |
| Notal Vision, Inc. | 1 | $64 |
| Eyepoint US, Inc. | 3 | $55 |
| Harrow Eye, LLC | 1 | $26 |
| Vyera Pharmaceuticals, LLC | 1 | $20 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$27,622
- EYLEA HD$17,688
- Lucentis$9,900
- Izervay$6,429
- BEOVU$6,300
- SUSVIMO$3,831
- OZURDEX$1,962
- Syfovre$686
- Constellation$252
- Unity$140
- IC-8 Apthera IOL$123
- enVista MX60 IOL$123
- Oxervate$121
- XIPERE$117
- CEQUA$116
- OMNI(R) SURGICAL SYSTEM (US)$104
- Clareon$102
How this compares
$83,377 in reported general payments places this provider in the 90th percentile of 47 retina specialist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bromfenac Sodium | 67 | $9,343 |
| Prednisolone Acetate | 107 | $6,581 |
| Ketorolac Tromethamine | 98 | $2,486 |
| Brimonidine Tartrate | 37 | $1,357 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 19 | $399 |
| Ofloxacin | 22 | $376 |
| Dorzolamide Hcl | 30 | $371 |
| Latanoprost | 17 | $111 |
| Timolol Maleate | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Silver Spring
- Joshua FernandesSilver Spring$500
- Rohit LakhanpalOwings Mills$168K
- Brian DoChevy Chase$116K
- Adam GerstenblithHagerstown$107K
- Michael ElmanBaltimore$27K
- Reginald SandersGreenbelt$24K
- Sidney SchechetBaltimore$23K
- Mohsin AliGreenbelt$14K
- Michael LaiChevy Chase$13K
- Robert ParnesHagerstown$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.